By inhibiting a particular family of enzymes, it may be possible to develop new therapies for treating neurodegenerative diseases from glaucoma to Alzheimer’s December 14, 2020 | By Scott LaFee Many neurodegenerative conditions, from glaucoma to Alzheimer’s disease, are characterized...
November 13, 2020 | By Liezel Labios Researchers at the University of California San Diego have identified new mechanisms in neurons that cause Alzheimer’s disease. In particular, they discovered that changes in the structure of chromatin, the tightly coiled form...
